Literature DB >> 22001934

Reliability of the lay adherence counsellor administered substance abuse and mental illness symptoms screener (SAMISS) and the International HIV Dementia Scale (IHDS) in a primary care HIV clinic in Cape Town, South Africa.

Erica Breuer1, Kevin Stoloff, Landon Myer, Soraya Seedat, Dan J Stein, John Joska.   

Abstract

HIV infection is associated with an increased prevalence of common mental disorders and with the development of HIV associated neurological disorders (HAND). The aim of this research was to determine the reliability of lay adherence counsellors in the administration of the substance abuse and mental illness symptom screener (SAMISS) for common mental disorders and International HIV Dementia Scale (IHDS) for HAND in a South African sample of 269 people living with HIV/AIDS and on HAART in a primary healthcare setting. We used a cross-sectional design with each patient assessed by a mental health nurse and counsellor, 1 week apart. Reliability was fair for the SAMISS overall (κ = 0.39, CI(95) 0.29-0.49, P < 0.01), but was higher for the substance abuse component compared to the mental illness component. Reliability for the IHDS between counsellors and nurses was slight (κ = 0.11, CI(95) 0.00-0.27, P < 0.02). Counsellors tended not to miss symptoms, and detected symptoms more often than nurses for the both the SAMISS and IHDS. Strategies to improve the ability of primary healthcare providers to screen for neurocognitive disorders as well as avoiding over-detection of mental illness and substance abuse symptoms need to be developed and implemented for the primary healthcare setting.

Entities:  

Mesh:

Year:  2012        PMID: 22001934     DOI: 10.1007/s10461-011-0067-z

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  13 in total

1.  A Comparison of Five Brief Screening Tools for HIV-Associated Neurocognitive Disorders in the USA and South Africa.

Authors:  J A Joska; J Witten; K G Thomas; C Robertson; M Casson-Crook; H Roosa; J Creighton; J Lyons; J McArthur; N C Sacktor
Journal:  AIDS Behav       Date:  2016-08

Review 2.  Epidemiology of neurodegenerative diseases in sub-Saharan Africa: a systematic review.

Authors:  Alain Lekoubou; Justin B Echouffo-Tcheugui; Andre P Kengne
Journal:  BMC Public Health       Date:  2014-06-26       Impact factor: 3.295

Review 3.  Screening for HIV-Associated Neurocognitive Disorders: Sensitivity and Specificity.

Authors:  Reuben N Robbins; Travis M Scott; Hetta Gouse; Thomas D Marcotte; Sean B Rourke
Journal:  Curr Top Behav Neurosci       Date:  2021

4.  Cross-country variations in the reporting of psychotic symptoms among sub-Saharan African adults: A psychometric evaluation of the Psychosis Screening Questionnaire.

Authors:  Mary Bitta; Yanga Thungana; Hannah H Kim; Christy A Denckla; Amantia Ametaj; Mahlet Yared; Claire Kwagala; Linnet Ongeri; Rocky E Stroud; Edith Kwobah; Karestan C Koenen; Symon Kariuki; Zukiswa Zingela; Dickens Akena; Charles Newton; Lukoye Atwoli; Solomon Teferra; Dan J Stein; Bizu Gelaye
Journal:  J Affect Disord       Date:  2022-02-18       Impact factor: 6.533

5.  Trail Making Test A improves performance characteristics of the International HIV Dementia Scale to identify symptomatic HAND.

Authors:  Thep Chalermchai; Victor Valcour; Pasiri Sithinamsuwan; Suteeraporn Pinyakorn; David Clifford; Robert H Paul; Somporn Tipsuk; James L K Fletcher; Victor Degruttola; Silvia Ratto-Kim; Nicholas Hutchings; Cecilia Shikuma; Jintanat Ananworanich
Journal:  J Neurovirol       Date:  2013-03-13       Impact factor: 2.643

6.  Exploring the utility of the Montreal Cognitive Assessment to detect HIV-associated neurocognitive disorder: the challenge and need for culturally valid screening tests in South Africa.

Authors:  Reuben N Robbins; John A Joska; Kevin G F Thomas; Dan J Stein; Teboho Linda; Claude A Mellins; Robert H Remien
Journal:  Clin Neuropsychol       Date:  2013-01-21       Impact factor: 3.535

7.  A Mobile App to Screen for Neurocognitive Impairment: Preliminary Validation of NeuroScreen Among HIV-Infected South African Adults.

Authors:  Reuben N Robbins; Hetta Gouse; Henry G Brown; Andries Ehlers; Travis M Scott; Cheng-Shiun Leu; Robert H Remien; Claude A Mellins; John A Joska
Journal:  JMIR Mhealth Uhealth       Date:  2018-01-05       Impact factor: 4.773

8.  Feasibility and Acceptability of a Task-Shifted Intervention to Enhance Adherence to HIV Medication and Improve Depression in People Living with HIV in Zimbabwe, a Low Income Country in Sub-Saharan Africa.

Authors:  Melanie Abas; Primrose Nyamayaro; Tarisai Bere; Emily Saruchera; Nomvuyo Mothobi; Victoria Simms; Walter Mangezi; Kirsty Macpherson; Natasha Croome; Jessica Magidson; Azure Makadzange; Steven Safren; Dixon Chibanda; Conall O'Cleirigh
Journal:  AIDS Behav       Date:  2018-01

9.  A pilot study of a nurse-delivered cognitive behavioral therapy intervention (Ziphamandla) for adherence and depression in HIV in South Africa.

Authors:  Lena S Andersen; Jessica F Magidson; Conall O'Cleirigh; Jessica E Remmert; Ashraf Kagee; Matthew Leaver; Dan J Stein; Steven A Safren; John Joska
Journal:  J Health Psychol       Date:  2016-04-26

10.  How faithfully do HIV clinicians administer the PHQ-9 depression screening tool in high-volume, low-resource clinics? Results from a depression treatment integration project in Malawi.

Authors:  Brian W Pence; Melissa A Stockton; Steven M Mphonda; Michael Udedi; Kazione Kulisewa; Bradley N Gaynes; Mina C Hosseinipour
Journal:  Glob Ment Health (Camb)       Date:  2019-10-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.